Rophelin
Rophelin, licence 00489522: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Tussilyn 2
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 00489522
- Status
- Inactive licence
- Licence date
- 24 October 2007
- Revision date
- 9 May 2018
- Form
- Liquide
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Caramel, l-Menthol, Eucalyptol, Glycérine, Benzoate de sodium, Sorbate de potassium, Sorbitol 70%, Sucrose, propylèneglycol, Eau purifiée, Glucose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | 1.0 Cuillère à thé | maximum: 4.0 Tous les jours |
| Adultes | Not specified | 2.0 Cuillère à thé | maximum: 4.0 Tous les jours |
Uses authorised in Canada
Favorise l'expectoration et aide à soulager la toux causée par le rhume et la bronchite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser en cas de grossesse ou d'allaitement.
Source
Official Health Canada record, licence 00489522
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.